PLSE · Pulse Biosciences, Inc.

$36.97 +1.84 (+5.24%)

Market Cap

$2.43B

69.21M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-07-29	—
Investor Event Transcript	2026-06-30	—
Investor Event Transcript	2026-06-30	—
Investor Event Transcript	2026-06-30	—
8-K	2026-06-12	2026-06-11
8-K	2026-06-10	—
10-Q	2026-05-14	2026-03-31
DEF 14A	2026-05-11	2026-06-11
8-K	2026-05-06	2026-05-05
8-K	2026-05-04	—
10-K/A	2026-04-30	2025-12-31
8-K	2026-04-27	2026-04-25
8-K	2026-04-16	—
8-K	2026-04-09	2026-04-08
8-K	2026-04-07	—
Investor Event Transcript	2026-03-31	—
Investor Event Transcript	2026-03-31	—
Investor Event Transcript	2026-03-31	—
8-K	2026-03-27	2026-03-23
8-K	2026-03-17	—
8-K	2026-03-12	—
8-K	2026-03-09	2026-03-06
8-K	2026-03-03	—
8-K/A	2026-03-02	2026-02-27
8-K	2026-02-27	—
8-K	2026-02-19	—
8-K	2026-02-19	2026-02-18
10-K	2026-02-19	2025-12-31
8-K	2026-02-06	2026-02-05
8-K	2026-01-14	—
8-K	2026-01-09	2026-01-08
8-K	2025-12-18	—
8-K	2025-12-12	2025-12-09
8-K	2025-12-09	—
8-K	2025-11-13	—
10-Q	2025-11-05	2025-09-30
8-K	2025-11-05	—
DEF 14A	2025-10-28	2025-12-09
8-K	2025-10-24	—
8-K	2025-10-10	—
8-K	2025-10-01	2025-09-30
8-K	2025-09-08	—
DEF 14A	2025-09-03	2025-09-30
8-K	2025-09-02	—
8-K	2025-08-26	—
10-Q	2025-08-12	2025-06-30
8-K	2025-08-12	—
8-K	2025-07-14	—
10-Q	2025-05-08	2025-03-31
8-K	2025-05-08	—

Showing 1–50 of 170 filings

Key facts CIK 1625101 CUSIP 74587B101 13F (30d) 15 filings 15 filers Visit website Investor relations